Monthly Activities/Appendix 4C Cash Flow Report
Filed with ASX · · 10 pages · English
Lumos Diagnostics Holdings Ltd. on 6ix
In the deck
Earlier from Lumos Diagnostics
- Update on Economic Evaluation of FebriDx
- Economic Evaluation of FebriDx
- U.S FDA Deprioritises EUA Application for CoviDx
- FY21 Full Year Results
- FY21 Full Year Results Investor Presentation
Later from Lumos Diagnostics
- LDX received authorization to sell CoviDx in Canada
- Lumos Receives Initial Orders for CoviDx In Canada
- Lumos Provides ViraDx and FebriDx Regulatory Update
- Over 100 Pharmacies in Liverpool UK Launch FebriDx Service
- Victorian Government Intent for Lumos Manufacturing Hub
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics